Australia Enacts Ban on Genetic Test Results in Life Insurance Underwriting

The Act introduces a new section, 33H, into the Insurance Contracts Act, creating a strict liability offence for insurers who solicit or use 'protected genetic information' when making life insurance contract decisions. This means that insurers are legally barred from requesting or considering the results of genetic tests when assessing applications for life insurance coverage.

'Protected genetic information' is defined within the Act as information about an individual's genetic makeup that has been obtained through genetic testing. This encompasses data that could indicate a predisposition to certain medical conditions or diseases. By restricting the use of such information, the legislation aims to prevent discrimination based on genetic predispositions and to ensure that individuals are not deterred from undergoing genetic testing due to fears of insurance repercussions.

The term 'solicit' in this context refers to any action by an insurer to request or encourage an individual to provide their genetic test results. This includes direct requests during the application process or indirect methods that could pressure applicants into disclosing such information. The legislation makes it clear that any form of solicitation or use of genetic test results in life insurance underwriting is prohibited.

Life insurance contract decisions impacted by this ban include the assessment of applications, determination of premiums, and decisions regarding the terms and conditions of coverage. Insurers must now base their underwriting decisions on other relevant factors that do not involve genetic test results.

In addition to the amendments to the Insurance Contracts Act, the legislation also introduces changes to the Disability Discrimination Act. These amendments reinforce the prohibition against discrimination based on genetic information, aligning with the broader objectives of the new law to protect individuals from unfair treatment due to their genetic characteristics.

The Act includes a provision for a review after five years to assess its effectiveness and to determine whether further amendments are necessary. This review will consider the impact of the legislation on the life insurance industry and on consumers, ensuring that the objectives of protecting privacy and preventing discrimination are being met.

For health care professionals, this legislation is particularly relevant. It underscores the importance of understanding the legal landscape surrounding patient information and the implications for insurance coverage. Health care providers should be aware of these changes to advise patients appropriately and to ensure compliance with the new regulations.

In summary, the passage of the Treasury Laws Amendment (Genetic Testing Protections in Life Insurance and Other Measures) Act 2026 marks a significant step in safeguarding consumer privacy and preventing genetic discrimination in the life insurance sector. By prohibiting the use of genetic test results in underwriting decisions, the legislation aims to encourage individuals to participate in genetic testing without fear of insurance-related consequences, ultimately promoting better health outcomes and equity in insurance practices.